(Q36424212)

14 August 2017

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa (English)

1 reference

14 August 2017

0 references

Gesine Meyer-Rath

2

0 references

Kathryn Schnippel

Kathryn Schnippel

1

0 references

William B MacLeod

William MacLeod

4

0 references

Lawrence Long

Lawrence Long

3

0 references

Sydney Rosen

Sydney Rosen

7

0 references

Ian Sanne

5

Ian Sanne

1 reference

14 August 2017

6

Wendy S Stevens

1 reference

14 August 2017

12 June 2012

1 reference

Tropical Medicine and International Health

14 August 2017

1 reference

14 August 2017

17

1 reference

14 August 2017

9

1 reference

14 August 2017

1142-1151

1 reference

The impact and cost of scaling up GeneXpert MTB/RIF in South Africa

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Rapid molecular detection of tuberculosis and rifampin resistance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506730

Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact

30 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03028.X

Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03028.X

Tuberculosis Diagnosis — Time for a Game Change

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22686606

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Xpert TB diagnostic highlights gap in point-of-care pipeline

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22686606

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22686606

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-3156.2012.03028.X

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

3506730